MENU
+Compare
OCS
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$21.75
Change
+$0.20 (+0.93%)
Capitalization
1.14B

OCS Oculis Holding AG Forecast, Technical & Fundamental Analysis

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care... Show more

OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OCS with price predictions
Oct 17, 2025

OCS in +1.83% Uptrend, rising for three consecutive days on October 17, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OCS advanced for three days, in of 149 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on OCS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

OCS moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OCS crossed bullishly above the 50-day moving average on October 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 216 cases where OCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OCS broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.337) is normal, around the industry mean (24.226). P/E Ratio (63.076) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (349.660).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCPSX45.690.43
+0.95%
Communication Services UltraSectorProSvc
FAFCX34.270.27
+0.79%
Fidelity Advisor Financials C
JNBZX10.440.01
+0.10%
JPMorgan Income Builder R6
ADOCX19.30-0.09
-0.46%
Alger Dynamic Opportunities C
LADRX23.39-0.18
-0.76%
Lord Abbett Developing Growth R3

OCS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+0.93%
CUE - OCS
36%
Loosely correlated
+0.77%
CGEN - OCS
35%
Loosely correlated
-3.85%
SNSE - OCS
32%
Poorly correlated
-33.43%
PRAX - OCS
29%
Poorly correlated
+16.77%
GRI - OCS
29%
Poorly correlated
-0.51%
More